SCHEMBL7305582

SCHEMBL7305582

O=c1[nH]c(=O)n(CCCCCl)c2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 1/20 0.50
DRD2 P14416 1/20 0.50
HTR2A P28223 1/20 0.50
PARP1 P09874 6/20 0.49
DAO P14920 1/20 0.48
POLB P06746 1/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
MAPT P10636 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
TYMP P19971 1/20 0.43
TNKS O95271 1/20 0.42
FABP4 P15090 1/20 0.42
FABP5 Q01469 1/20 0.42
P2RX4 Q99571 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649804 0.98 HTR1A (0.49) HTR1ADRD2HTR2APARP1DAO
SCHEMBL446902 0.95 PARP1 (0.50) HTR1ADRD2HTR2APARP1DAO
SCHEMBL11010372 0.89 PARP1 (0.52) HTR1ADRD2HTR2APARP1DAO
SCHEMBL7650175 0.85 PARP1 (0.50) HTR1ADRD2HTR2APARP1DAO
SCHEMBL7750879 0.85 PGR (0.55) HTR1ADRD2HTR2APARP1DAO
SCHEMBL7298333 0.85 ALDH1A1 (0.55) HTR1ADRD2HTR2APARP1DAO
SCHEMBL6295463 0.83 PARP1 (0.50) HTR1ADRD2HTR2APARP1DAO
SCHEMBL6028786 0.83 PGR (0.60) HTR1ADRD2HTR2APARP1DAO
SCHEMBL10827376 0.83 PARP1 (0.50) HTR1ADRD2HTR2APARP1DAO
SCHEMBL29528989 0.83 PGR (0.60) HTR1ADRD2HTR2APARP1DAO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed